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Assessing structure and function of myelin
in cervical spondylotic myelopathy
Evidence of demyelination
ABSTRACT
Purpose: To assess the extent of demyelination in cervical spondylotic myelopathy (CSM) using
myelin water imaging (MWI) and electrophysiologic techniques.
Methods: Somatosensory evoked potentials (SSEPs) and MWI were acquired in 14 patients with
CSM and 18 age-matched healthy controls. MWI was performed on a 3.0T whole body magnetic
resonance scanner. Myelin water fraction (MWF) was extracted for the dorsal columns and whole
cord. SSEPs and MWF were also compared with conventional MRI outcomes, including T2 signal
intensity, compression ratio, maximum spinal cord compression (MSCC), and maximum canal
compromise (MCC).
Results: Group analysis showed marked differences in T2 signal intensity, compression ratio,
MSCC, and MCC between healthy controls and patients with CSM. There were no group differ-
ences in MWF and SSEP latencies. However, patients with CSMwith pathologic SSEPs exhibited
reduction in MWF (p , 0.05). MWF was also correlated with SSEP latencies.
Conclusion: Our findings provide evidence of decreased myelin content in the spinal cord associ-
ated with impaired spinal cord conduction in patients with CSM. While conventional MRI are of
great value to define the extent of cord compression, they show a limited correlation with func-
tional deficits (i.e., delayed SSEPs). MWI provides independent and complementary readouts to
spinal cord compression, with a high specificity to detect impaired conduction. Neurology®
2017;89:602–610
GLOSSARY
CSM 5 cervical spondylotic myelopathy; DTI 5 diffusion tensor imaging; GLM 5 general linear model; JOA 5 Japanese
Orthopaedic Association; MCC 5 maximum canal compromise; MR 5 magnetic resonance; MSCC 5 maximal spinal cord
compression;MWF 5 myelin water fraction; MWI 5 myelin water imaging; ROI 5 region of interest; SSEP 5 somatosensory
evoked potential; TE 5 echo time; TR 5 repetition time.
Surgical intervention is the frontline strategy to relieve neurologic symptoms associated with cer-
vical spondylotic myelopathy (CSM).1,2 The key to achieving good surgical outcomes is timely
and accurate diagnosis. This relies on assessing a combination of clinical symptoms and findings
on MRI.3,4 However, routine MRI outcomes, such as maximal spinal cord compression
(MSCC) and the presence of signal intensity changes, are not always sensitive to identify
clinically relevant pathologies (i.e., those warranting surgical intervention). This is a major
problem because an estimated 20%–25% of otherwise healthy individuals will present with
some form of compression, not all of which requires intervention.5
Evidence from postmortem histologic studies demonstrates that demyelination occurs at the
lesion site in patients with CSM.6 In vivo morphologic evidence of demyelination, however, is
lacking. To date, a major limitation of studies applying advanced quantitative imaging in
patients with CSM has been that many measures are not specific for myelin.7,8 For example,
fractional anisotropy, an output from diffusion tensor imaging (DTI), can be dramatically
*These authors contributed equally to this work as first authors.
†These authors contributed equally to this work as last authors.
From Physics and Astronomy (H.L., A.L.M., B.M.), ICORD (H.L., C.R.J., M.F.D., C.L., J.L.K.K.), Medicine (Neurology) (E.L.M., E.L., S.H.K.,
D.K.B.L.), Radiology (A.L.M., D.K.B.L., C.L.), Orthopaedics (M.F.D.), Pathology & Laboratory Medicine (C.L.), and School of Kinesiology (J.L.
K.K.), University of British Columbia, Vancouver, Canada; Spinal Cord Injury Center (C.R.J., A.C.), University Hospital Balgrist, University of
Zurich, Switzerland; and Philips Healthcare (B.M.), Hamburg, Germany.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
602 © 2017 American Academy of Neurology
ª 2017 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
affected by axonal loss or mechanical deforma-
tion without relevant demyelination. To
address this limitation, we applied an MRI
technique specific to myelin, so-called myelin
water imaging (MWI), to examine pathology
in the spinal cord related to CSM.
METHODS Standard protocol approvals, registrations,
and patient consents. All individuals provided written
informed consent and all procedures described below were in
accordance with the Declaration of Helsinki and approved by
the local ethics board (UBC CREB #H06-00282).
Participants. A total of 15 patients with CSM were recruited
from the Vancouver Spine Program. CSM was determined based
on typical clinical symptoms (e.g., clumsiness in the hands, pain,
weakness, numbness, sensorimotor deficit) and evaluation of con-
ventional MRI by the study neurologist (A.C.). No patients with
CSM have undergone decompressive surgery. Twenty age- and
sex-matched healthy individuals from the community were
enrolled as healthy controls.
Clinical assessments. Prior to the MRI, all individuals were in-
terviewed to assess their general health and well-being by using
the Short Form–36 questionnaire.9,10 In individuals with CSM,
the modified Japanese Orthopaedic Association (JOA) score was
used to assess the severity of clinical symptoms.11,12 The Nurick
Score was used for stratifying the level of functional restriction in
mobility (grade O to 5: 0 5 no evidence of spinal cord disease,
5 5 chair- or bed-bound) caused by cervical myelopathy.13 The
neurologic level of stenosis was determined using the Interna-
tional Standards for Neurological Classification of Spinal Cord
Injury published by the American Spinal Injury Association.14
Electrophysiology. Standard tibial somatosensory evoked po-
tentials (SSEPs) were elicited through repetitive electrical
stimulation (repetitive square wave impulse of 0.5-ms duration)
of the posterior tibial nerves at the medial ankle. SSEPs were
elicited using self-adhesive bipolar stimulation electrodes and the
Keypoint recording device (Medtronic; Minneapolis, MN).
Cortical responses (N40-P43) were recorded using silver–silver
disc recording electrodes that were positioned according to the
10–20 system, with the active electrode at Cz and referenced to
Fz. In addition to the cortical response, evoked responses were
acquired at the popliteal fossa (N9, peripheral measure of the
afferent volley) to assure appropriate stimulation and exclude
impairment of peripheral nerve conduction. Stimulation fre-
quency was set at 3.1 Hz and 2 traces of 200 stimulations were
applied per site and eventually averaged for visual detection of
N40-P43 waveform. Electrode impedance was kept below 5kV,
which was verified prior to the initiation of each session, and all
signals were sampled at 10 kHz and bandpass filtered 2 Hz to
2 kHz. Averaged SSEPs were visually inspected for N40 and P43
latencies and N40-P43 amplitude. Accounting for study partici-
pant height, SSEP amplitude, latency, and configuration were
evaluated against standard laboratory control values.15
MRI experiments. All individuals were scanned on a 3.0TMRI
system (Philips; Best, the Netherlands) with a phased array spine
coil using only the first 4 channels for best localization of the cer-
vical spinal cord. Localizer and sagittal T2-weighted imaging se-
quences (repetition time [TR] 3,314 ms, echo time [TE] 120 ms)
were applied first for the purposes of spinal cord localization and
axial slices alignment. MWI was performed using a multiecho T2
relaxation experiment (3D 32-echo sequence, 1st echo 10 ms,
echo spacing 10 ms, TR 1,300 ms, eight 5-mm-thick axial slices
perpendicular to the spinal cord, 256 3 128 matrix, field of
view 180 3 135 mm, reconstructed in-plane resolution
0.7 3 0.7 mm, acquisition time of 20.3 minutes).16 Positioning
of the 3D stack was centered at the level of stenosis in participants
with CSM. C5 was planned for all healthy controls based on the
rationale that the majority of participants with CSM would have
stenosis at or within one spinal segment (i.e., C4–C6). A previous
study indicates minimal variation in MWF between cervical
spinal segments.17 The MWI scan–rescan repeatability was tested
and reported by MacMillan et al.18
MWI data analysis. Voxel-wise T2 decay curve analysis used
a regularized non-negative least squares algorithm with in-house
software (MATLAB; The MathWorks, Inc., Natick, MA),
which employed the extended phase graph algorithm to estimate
the refocusing flip angle in each voxel as well as correcting the T2
decay curve for stimulated echo artifacts. This algorithm and its
performance have been documented by Prasloski et al.19 The
MWF, which measures water trapped between myelin bilayers,
was defined as the fractional signal with T2 less than 35 ms.18
MWF was calculated for each voxel to produce a MWF map. For
each study participant, the average MWF in the whole cord and
dorsal column were calculated in 3 steps using FMRIB’s software
library20 (figure 1): (1) manually drawing regions of interest (ROI
includes dorsal columns and whole cord), independently per-
formed by 2 experienced researchers (H.L., C.L.), on each slice of
T2-weighted images (TE 90–120 ms) from the 3D multiecho T2
experiment for better anatomical contrast; (2) combining the
ROIs over the 6 middle slices (the first and last slices are discarded
due to phase wrapping in the through-plane direction) to yield
a volume of interest; (3) calculating the average MWF within the
volume of interest.
Compression ratio, MSCC, and maximum canal
compromise. Axial and sagittal T2-weighted images were
examined for T2 intensity signal changes at the level of stenosis,
Figure 1 Work flowchart
An example of calculating the average myelin water fraction (MWF) in the whole cord and
dorsal column. FSL 5 FMRIB software library.
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Figure 2 Calculations of conventional MRI measures and comparisons between healthy controls and patients
with cervical spondylotic myelopathy (CSM)
(A, B) The methods for calculating compression ratio, maximum spinal cord compression (MSCC), and maximum canal com-
promise (MCC). D1 5 transverse diameter; D2 5 anterior–posterior diameter; Di (di) 5 canal (spinal cord) diameter at com-
pression level; Da (da)5 canal (spinal cord) diameter of noncompressed level from above; Db (db): canal (spinal cord) diameter
of noncompressed level from below. (C) Significant differences were observed in compression ratio, MSCC, and MCC
between healthy controls and patients with CSM.
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compression ratio, MSCC, and maximum canal compromise
(MCC). T2 intensity changes were examined by an experienced
radiologist. Compression ratio was calculated by taking the
anterior–posterior diameter of the spinal cord divided by the
transverse diameter of the cord on the axial image. Lower com-
pression ratio values indicate worse cord deformation. MSCC and
MCC were assessed on the midsagittal slice of the T2-weighted
spinal cord images using the method introduced by Nouri et al.21
Unlike compression ratio, higher values of MSCC and MCC
correspond to more severe cord deformation. Detailed calculation
steps for compression ratio, MSCC, and MCC are described in
figure 2, A and B.
Statistical analysis. All statistical procedures were performed
using IBM’s (Armonk, NY) Statistical Package for the Social
Sciences, version 23.0. Nonparametric tests (Mann-Whitney U)
were applied to determine significant differences in spinal cord
compression, anterior–posterior width, and transverse (left–right)
and tibial SSEP latencies between control individuals and patients
with CSM. Univariate general linear models (GLMs) were em-
ployed to assess the relationship between MWF, SSEPs, and
CSM classification. In the initial models (model 1), the main
effect of CSM classification was examined. CSM was included as
a fixed factor (“yes”/“no”). In a subsequent model (model 2),
SSEPs (“normal”/“pathologic”) and the interaction with CSM
classification were examined. GLMs were run separately for dorsal
column and whole cord and right and left SSEPs. p , 0.05 Was
set as the threshold for significance.
RESULTS Participants.Out of 15 patients with CSM
enrolled in the study, one had to be excluded due to
an incomplete dataset (missing magnetic resonance
[MR] scan for MWI). The remaining 14 patients
comprised 11 men and 3 women with a mean age
of 61.0 6 9.3 years (range 46–77 years). According
to established classification guidelines,22 CSM sever-
ity was as follows: 11 mild (JOA $15), 2 moderate
(JOA 12–14), and 1 severe (JOA ,12). Out of 20
healthy controls, 2 had to be excluded for missing
data (i.e., could not perform MRI). The remaining
18 healthy controls were enrolled in the study (9
men, 9 women, mean age 58.5 6 7.6 years (range
50–75 years). The characteristics of all study partic-
ipants are summarized in table 1.
Neuroimaging: Structural and signal changes at the spinal
cord. Overall, compression ratio was increased by
35.3% (U 5 35.0, p 5 0.001) in the patients with
CSM at the level of stenosis compared to healthy
controls at the level of C5. Compared to healthy
controls, differences in anterior–posterior width
were observed in patients with CSM (228.1%;
U 5 26.5, p 5 0.002). No differences between
Table 1 Demographic, neuroimaging, and neurophysiologic details of the study cohorts
Measures Healthy controls
Patients with
CSM
Pairwise
comparisons, p
Demographics
Male:female 9:9 9:5
Age, y 58.5 6 7.6 61.0 6 9.3 0.411
Height, cm 171.1 6 8.7 167.2 6 10.5 0.274
JOA score 16.9 6 0.4 14.9 6 2.4 0.002
Neuroimaging measures
T2 signal changes, yes:no 0:18 10:4
Spinal cord compression ratio 0.46 6 0.09 0.34 6 0.1 0.002
Anterior–posterior width, mm 5.7 6 0.9 4.1 6 1.6 0.001
Transverse width, mm 12.6 6 0.9 12.1 6 1.6 0.290
Maximum spinal cord compression 7.5 6 4.9 27.0 6 15.0 0.0001
Maximum canal compromise 16.8 6 8.4 42.9 6 12.1 ,0.0001
Myelin water fraction whole cord 0.26 6 0.03 0.24 6 0.04 0.166
Myelin water fraction dorsal column 0.28 6 0.04 0.27 6 0.04 0.283
Compression level, no. of participants
C4/C5 2 2
C5/C6 3 11
C6/C7 1
Neurophysiologic parameters
Left tibial SSEP N40 latency, ms 44.0 6 4.2 43.7 6 3.8 0.873
Right tibial SSEP N40 latency, ms 44.8 6 7.1 43.4 6 3.5 0.514
Abbreviations: CSM 5 cervical spondylotic myelopathy; JOA 5 Japanese Orthopaedic Association; SSEP 5 somatosen-
sory evoked potential.
Results are displayed as mean 6 SD.
Neurology 89 August 8, 2017 605
ª 2017 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
control and CSM groups were detected regarding
transverse (left–right) axis (U 5 85.5, p 5 0.270).
Compression ratio, MSCC, MCC, and compression
levels are shown in table 1. Five healthy controls and all
patients with CSM were found to have spinal cord
compression. T2 signal changes (hyperintensity) were
observed in 10 patients with CSM but not in controls.
Corresponding with diagnosis of CSM, there were large
differences in compression ratio, MSCC, and MCC
between controls and patients with CSM (table 1).
Neurophysiologic assessments: Changes in spinal conduc-
tion and associations with conventional MRI outcomes.
Tibial SSEP latencies of both groups are summa-
rized in table 1. Mean latencies for tibial (left or
right) were not different between patients with
CSM and healthy controls (tibialleft: U 5 115,
p 5 0.891; tibialright: U 5 112.0, p 5 0.781)
(figure 3A). Eight healthy controls and 8 patients
with CSM were classified as having pathologic
SSEPs.
Figure 3 Myelin water fraction (MWF) and somatosensory evoked potentials (SSEPs) comparisons between healthy controls and patients
with cervical spondylotic myelopathy (CSM) and interaction effect
(A) MWF (whole cord and dorsal column) and tibial SSEP latencies (left and right) between healthy controls and patients with CSM are compared.
No differences were observed between groups. (B) An interaction between the interpretation of tibial SSEPs (“pathology”/“normal”) and
the diagnosis of CSM (“yes”/“no”) was observed for MWF of the whole cord. Patients with CSM and pathologic tibial SSEPs had reduced MWF
(indicated by *).
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Myelin damage in patients with CSM: Relationship
between neurophysiologic and neuroimaging parameters.
According to our first GLM (model 1), there were no
differences in MWF of the whole cord (F 5 2.015,
df 1, p 5 0.166) or dorsal column (F 5 1.192, df 1,
p 5 0.284) between CSM and controls (figure 3A).
Model 2 revealed an interaction between CSM clas-
sification and SSEP interpretation in whole cord
MWF (left SSEP: F 5 7.82, df 3, p 5 0.009; right
SSEP: F 5 4.77, df 3, p 5 0.049). Overall, our
observations indicate that patients with CSM and
pathologic tibial SSEPs had marked lower myelin
content. Model summaries for linear regressions are
provided in table e-1 at Neurology.org.
Other analyses pertaining to the relationship
between MWF and CSM are highlighted in tables
e-2 and e-3.
DISCUSSION Based on an in vivo measure specific
to myelin, our findings demonstrate that CSM is
associated with microstructural changes in spinal cord
white matter. Microstructural changes in myelin were
demonstrated using MWI and evidenced in a cohort
of patients with CSM with accompanying neurophys-
iologic deficits. We have provided in vivo anatomical
evidence of demyelination related to conduction def-
icits in patients with CSM.
MWF as a surrogate marker of myelin has previ-
ously been demonstrated in postmortem combined
MRI and histologic studies.23–25 Consistent with
these ex vivo observations, MWF is sensitive to
changes in patient populations commonly associated
with demyelination in the CNS, including multiple
sclerosis,26,27 phenylketonuria,28 and schizophrenia.29
MWI operates on the principle that the MR signal
from water trapped between myelin bilayers can be
extracted from the total MR signal based on a charac-
teristic short T2 relaxation time. The ratio of myelin
water signal relative to the total signal is termed mye-
lin water fraction (MWF). The primary focus of
Figure 4 Correlations between somatosensory evoked potentials (SSEPs) and myelin water fraction (MWF) in patients with cervical
spondylotic myelopathy (CSM) and healthy controls
Correlations of tibial SSEPs (left and right) with dorsal column and whole cord MWF in participants with CSM (A–D) and healthy controls (E–H). Significant
correlations are only found in the CSM group (trend lines are fitted R2 and p value). No correlations are observed in healthy controls.
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in vivo MWF applications in patients has been almost
exclusively in the brain.
Postmortem histologic study of spinal cords sug-
gests that myelinated long tracts are affected in pa-
tients with CSM.6 This includes evidence of
demyelination at the lesion site. Preclinical studies
suggest that CNS myelin is susceptible to ischemic
injury resulting from spinal cord compression.30
Corresponding in vivo evidence of white matter
pathology has been largely elucidated based on
DTI.31–33 Results from DTI measurement showed
strong sensitivity for detecting microstructural
changes and correlations with clinical scores. How-
ever, DTI metrics are not specific to the type of
damage, which may include a combination of
inflammation, demyelination, or axonal loss.7 Thus,
based solely on these studies, it is difficult to con-
clude whether CSM is affecting myelin or, more
generally, the composition of spinal cord axons due
to mechanical deformation.
Few studies have applied both quantitative MRI
and an electrophysiologic approach to examine
CSM.34,35 The advantage of combining both techni-
ques is that they are unbiased by what an individual is
functionally capable of performing (e.g., JOA). This
combined approach is powerful for understanding the
pathophysiology and anatomy of CSM.35 An impor-
tant outcome of our study was that conventional
CSM diagnosis alone yielded no obvious differences
in neurophysiologic or MWI measures (figure 3A).
Consistent with previous literature, approximately
60% of patients with CSM in our study presented
with pathologic SSEPs.36 An equal number (n 5 8)
and approximately half of healthy controls also dem-
onstrated pathologic SSEPs. MWF values in healthy
controls were comparable to previous studies,17,18,37
and not different from patients with CSM on a group
level. In contrast to healthy controls, pathologic SSEP
classification in individual patients with CSM was
associated with reduced MWF (figure 3). In prag-
matic terms, this means that microstructural changes
in white matter become evident in clinically obvious
CSM symptoms (e.g., clumsiness) that are also
accompanied by objective measures of spinal cord
pathology (e.g., impaired SSEPs). The linear correla-
tions of SSEP latency and MWF (dorsal column and
whole cord) are also only observed in patients with
CSM (figure 4). From pathophysiologic considera-
tions, decreases in MWF are not linearly related to
pathologic SSEPs, as shown in healthy controls.
Obviously changes in SSEPs in healthy aged controls
respond also to other change in CNS and peripheral
nervous system microstructure, which are undetected
by MWI of the cord. The age-matched patients
with CSM would be expected to undergo these same
changes; however, additionally accompanied by
persistent compression of the spinal cord, the latter
yielding a reduction in MWF.
Our study specifically examined the spinal cord
MWF in patients with CSM. The application of
MWI to the spinal cord has historically lagged behind
that of brain studies due to the general technical chal-
lenges of imaging spinal cord microstructure using
MRI.38 By taking advantage of the development of
a 3D multiecho pulse sequence, it is now possible to
achieve multislice coverage of the spinal cord with
shorter acquisition time compared to previous single
slice acquisitions.37 Also, the in-plane resolution
(0.7 3 0.7 mm) is sufficient to resolve detailed ana-
tomical structures (e.g., the butterfly pattern of white
and gray matter on the axial plane). Reliability and re-
peatability of applying MWI using the current 3D
multiecho sequence in cervical spinal cord are accept-
able and have been examined elsewhere.18 In all par-
ticipants, dorsal column MWF average (0.280 6
0.042) was higher than that of the whole cord
(0.253 6 0.040). Lower whole cord MWF reflects
the inclusion of unmyelinated gray matter in the
ROI, leading to lower relative values, in comparison
to the dorsal column ROIs, which are white matter.
A number of limitations warrant consideration.
First, the specificity and sensitivity of MWI to accu-
rately diagnose CSM cannot be fully addressed due
to the small number of patients. Second, manual
ROIs may introduce bias to the analysis. Future in-
vestigations should consider automatic segmentation
tools, which have only recently become available for
the spinal cord.39 Finally, the 20-minute acquisition
time for MWI is long and may be difficult for some
patients. Towards improving clinical applicability,
recent advances in MWI have dramatically reduced
scanning time to approximately 8 minutes.40
Combining neurophysiologic and neuroimaging
outcomes revealed considerable changes in white mat-
ter integrity related to spinal cord compression.
Microstructural changes in myelin were specifically
observed in a cohort of patients with pathologic spinal
conduction. In the future, MWI may be a useful tool
for prognosis related to interventions aimed at reduc-
ing the functional consequences of CSM.
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